Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 14751 - 14775 of 15332 in total

CLBS12

CLBS12 is a GCSF-mobilized autologous cell therapy derived from CD34+ cells being investigated for the treatment of Buerger’s disease.
Investigational

SER-287

SER-287 comprises healthy microbiome-derived Gram positive bacterial spores.
Investigational

Eneboparatide

Investigational

NX-210c

Investigational

Gresonitamab

Investigational

Vepsitamab

Investigational

Ifinatamab deruxtecan

Investigational

Haptoglobulin 1/1 (Plasma Derived)

Investigational

KB407

Investigational

Belcesiran

Investigational

SPK-7001

Investigational

M012

Investigational

Nadunolimab

Investigational

OAV401

Investigational

ET-101

Investigational

DR-01

DR-01 is a monoclonal antibody directed against human CD94.
Investigational

MRT5005

MRT5005 is a human cystic fibrosis transmembrane conductance regulator (hCFTR) messenger RNA (mRNA) complexed with branched polyethyleneimine (bPEI).
Investigational

C134

C134 is a genetically engineered oncolytic herpes simplex virus expressing human cytomegalovirus (HCMV) internal repeat short 1 (IRS1).
Investigational

A-16L

Investigational

Ulviprubart

Investigational

BVX-20

Investigational

OBI-888

Investigational

4A10

Investigational

SEA-BCMA

Investigational

M002

Investigational
Displaying drugs 14751 - 14775 of 15332 in total